Several studies on patients with malignant tumors have shown that compared with the use of serum albumin levels, body weight, or body mass index (BMI) alone, the GNRI is advantageous in prognostic evaluation (Kaito et al., 2020; Mizuno et al., 2019). This evidence concerns the gene ALB and cancer.